Digital & Innovation
Philips leader talks virtual care as key to a consumer-centric future of health
Digital & Innovation: In an interview with Health Industry Hub, Dan Ball, Leader APAC, EMR & Care Management at Philips, discussed the evolution of novel virtual health innovations and their accelerated adoption as a result of the COVID-19 pandemic.
Virtual care should be a foundational element of a consumer-centric future of health. Dan reflected on the benefits that have emerged and the key pain points impacting key stakeholders that still need to be addressed, including the current funding models.
Dan shared Philips’ virtual care strategy and how it is being integrated into the business. He noted “What we all need to take away from the last couple of years, as a group of stakeholders involved at our core around the patient, is to not let the momentum go. We have a great opportunity to really change the care models and the patient experience through healthcare in Australia. [Philips] is definitely excited to be part of the puzzle bringing that to the future.”
News & Trends - Biotechnology
AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm
Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]
MoreNews & Trends - MedTech & Diagnostics
Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis
MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]
MoreNews & Trends - MedTech & Diagnostics
Cardiac device benefits face more cuts, while technical services remain secure in the short term
MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]
MoreNews & Trends - Biotechnology
CSL’s world-first gene therapy heads for MSAC evaluation
Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]
More